Note: Ingredients listed on restricted chemical lists
EC/CAS
231-944-3/7779-90-0
Name of the chemical
Trizinc bis(orthophosphate)
Concentration
≤10 ≤5
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
≤3
EC/CAS
203-542-8/108-01-0
Name of the chemical
2-dimethylaminoethanol
Concentration
≥5% ≤0.3
EC/CAS
215-222-5/1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
≤0.3
General Information
Version
4
Revision date
2025-11-10
Product name
ABOLIT PRIMER - All variants
1.2.1 Relevant identified uses
Paint
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. H319 - Causes serious eye irritation. H411 - Toxic to aquatic life with long lasting effects.
Prevention
P280 - Wear protective gloves. Wear eye or face protection. P273 - Avoid release to the environment. P264 - Wash thoroughly after handling.
Response
P391 - Collect spillage. P362 + P364 - Take off contaminated clothing and wash it before reuse.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Irrit. 2, H315 Eye Irrit. 2, H319 Aquatic Chronic 2, H411 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
